704 Coronavirus RNA-binding domain (N-terminal part of Pfam 00937)
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organoheterocyclic compounds | 3 | 0.6 | 4.94× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 1.1 | 0.92× | not tested | |
| Homogeneous metal compounds | 1 | 1.9 | 0.52× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 1 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 1 |
| DB03685 | U5P | Uridine monophosphate | 1 |
| DB08348 | P34 | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | 1 |
| DB17038 | CQD | NSC-663284 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 15 |
| DJU | N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)methanamine | 5 |
| CL | CHLORIDE ION | 3 |
| U2H | ~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-yl)methyl]propan-1-amine | 3 |
| 657 | 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine | 2 |
| 9F2 | Ceftriaxone | 2 |
| A1H88 | 2-amino-1,3-benzothiazol-6-ol | 2 |
| CDmetal | CADMIUM ION | 2 |
| DJO | (phenylmethyl) (2S)-2-(hydroxymethyl)-2,3-dihydroindole-1-carboxylate | 2 |
| EJC | 5-propoxy-1H-indole | 2 |
| EY3 | 5-propan-2-yloxy-1H-indole | 2 |
| EY6 | 5-(2-fluoranylethoxy)-1H-indole | 2 |
| EY9 | 5-(2-methoxyethoxy)-1H-indole | 2 |
| NAmetal | SODIUM ION | 2 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 1 |
| AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLICACID | 1 |
| AMP | ADENOSINE MONOPHOSPHATE | 1 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 1 |
| CQD | 6-chloro-7-{[2-(morpholin-4-yl)ethyl]amino}quinoline-5,8-dione | 1 |
| IOD | IODIDE ION | 1 |